Metagenomi
Metagenomi is a biotechnology company that develops a natural microbial community platform to discover next-generation therapeutics by revealing novel cellular machinery from unknown organisms and reconstructing metagenomic ecosystems for breakthrough genome editing systems.
Metagenomi Overview
Metagenomi Funding Rounds
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | 1/5/2023 | ||||
| Series A | 4/7/2021 | ||||
| Series A | 8/13/2019 |
Metagenomi Investors
| Investor | Investment Rounds | Lead Partner | Initial Investment | Other Notable Investments |
|---|---|---|---|---|
| HOF Capital | Series A, Series B, Series A | Series A (2021-04-07) | ||
| Sozo Ventures | Series A, Series A | Series A (2021-04-07) | ||
| Bristol-Myers Squibb (NYS: BMY) | Series B | Series B (2023-01-05) | ||
| Irving Investors | Series B | Series B (2023-01-05) | ||
| Marshall Wace | Series B | Series B (2023-01-05) | ||
| Novo Holdings | Series B | Series B (2023-01-05) |
Metagenomi 409a Valuations
| Date | Price per share | Est. Valuation | Filling |
|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view |
Metagenomi Filings
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
